539 related articles for article (PubMed ID: 11840268)
1. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity.
Pierelli L; Marone M; Bonanno G; Rutella S; de Ritis D; Mancuso S; Leone G; Scambia G
Br J Haematol; 2002 Aug; 118(2):627-37. PubMed ID: 12139758
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
[TBL] [Abstract][Full Text] [Related]
5. TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
Koschmieder S; Hofmann WK; Kunert J; Wagner S; Ballas K; Seipelt G; Hoelzer D; Ottmann OG; Kalina U
Leukemia; 2001 Jun; 15(6):942-9. PubMed ID: 11417481
[TBL] [Abstract][Full Text] [Related]
6. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
7. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
9. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
Hayes SA; Huang X; Kambhampati S; Platanias LC; Bergan RC
Oncogene; 2003 Jul; 22(31):4841-50. PubMed ID: 12894225
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
11. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
Verma A; Deb DK; Sassano A; Uddin S; Varga J; Wickrema A; Platanias LC
J Biol Chem; 2002 Mar; 277(10):7726-35. PubMed ID: 11773065
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
15. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells.
Cao Z; Flanders KC; Bertolette D; Lyakh LA; Wurthner JU; Parks WT; Letterio JJ; Ruscetti FW; Roberts AB
Blood; 2003 Jan; 101(2):498-507. PubMed ID: 12393416
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase regulation of AP-2 binding in TGF-beta1-stimulated chondrogenesis of human trabecular bone-derived cells.
Tuli R; Seghatoleslami MR; Tuli S; Howard MS; Danielson KG; Tuan RS
Ann N Y Acad Sci; 2002 Jun; 961():172-7. PubMed ID: 12081893
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
Dai C; Yang J; Liu Y
J Biol Chem; 2003 Apr; 278(14):12537-45. PubMed ID: 12560323
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells.
Selvamurugan N; Fung Z; Partridge NC
FEBS Lett; 2002 Dec; 532(1-2):31-5. PubMed ID: 12459458
[TBL] [Abstract][Full Text] [Related]
19. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
Ducos K; Panterne B; Fortunel N; Hatzfeld A; Monier MN; Hatzfeld J
J Cell Physiol; 2000 Jul; 184(1):80-5. PubMed ID: 10825236
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms behind the dose-dependent differential activation of MAPK pathways induced by transforming growth factor-beta1 in hematopoietic cells.
Kale VP; Vaidya AA
Stem Cells Dev; 2004 Oct; 13(5):536-47. PubMed ID: 15588511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
